Apply to trial NCT06310551

A few quick questions so the study team can decide if you might be a fit.

RecruitingPhase 1Drug trial

First Time in Human Study of Long Acting VH4524184 Formulations

The purpose of this study is to identify 1 or more doses of parenterally administered VH4524184 that are safe, well tolerated and yield a PK drug exposure profile necessary to deliver a long-acting antiretroviral therapy for the treatment of HIV-1 infection.

How this works

Answer a few questions
About 5 to 10 minutes. Skip-friendly where possible.
We connect you with the study team
When a site picks up your application, we introduce you to their team directly — with you on the thread.
The team reaches out to schedule screening
Usually within a few business days, via the contact you give.

EmailWe save your progress under this email and copy you when we connect you with the study team.

I agree that Hipa.ai may share my application — my name, contact details, and my answers, including health information — with the official study team for this trial so they can review my responses and contact me.

By continuing, you agree to our terms of service.

First Time in Human Study of Long Acting VH4524184 Formulations

How this works

Answer a few questions

We connect you with the study team

The team reaches out to schedule screening